Dr. Shinichi Fukuhara Presents on Valve Reoperation After Native and Valve-In-Valve TAVR
Dr. Shinichi Fukuhara presented “Valve Reoperation after Native and Valve-in-Valve Transcatheter Aortic Valve Replacement: A Statewide Experience” during the American Association for Thoracic Surgery’s 102nd Annual Meeting which was held in Boston from May 14 – 17.
While the use of bioprostheses during SAVR has increased substantially, expecting future valve-in-valve TAVR (VIV-TAVR), there are scant data regarding reoperations following VIV-TAVR. Dr. Shinichi and team sought to investigate the characteristics and implications of patients undergoing aortic valve reoperations after native TAVR and VIV-TAVR.
The group found that approximately one-third of reoperations were VIV-TAVR cases, which demonstrated an exceedingly higher rate of reoperation compared with native TAVR. This fact challenges the worldwide trend of favoring bioprosthetic SAVR and presumptive future TAVR-in-SAVR concept. The frequent aortic repair during TAVR-explant in VIV-TAVR group appears mostly unrelated to TAVR explant trauma.
The co-authors of the study are Dr. Stephane Leung, Dr. Daizo Tanaka, Dr. Devraj Sukul, Dr. P. Michael Grossman, Dr. Stanley J. Chetcuti, Dr. Chang He, Melissa Clark, MSN, and Dr. Himanshu J. Patel.